Industry News
StairMed's penetrating BCI trial at Huashan reaches 18 cumulative implants
On 20 July 2026, at the World Artificial Intelligence Conference in Shanghai, StairMed disclosed that its cortex-penetrating invasive BCI clinical trial at Huashan Hospital has now reached 18 cumulative implants since March 2025. The Shanghai firm co-founded by Zhao Zhengtuo and Xue Li at the Chinese Academy of Sciences' Center for Excellence in Brain Science demonstrated a patient three months post-op controlling a wheelchair by thought and hitting 6.19 bits per second on a cursor task, alongside a live journalist test at 4.9 bits per second with a finger.